X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (25) 25
immunotherapy (22) 22
oncology (22) 22
melanoma (20) 20
humans (16) 16
article (12) 12
cancer (11) 11
immunology (10) 10
expression (9) 9
melanoma - pathology (9) 9
metastatic melanoma (9) 9
animals (8) 8
ipilimumab (8) 8
metastasis (8) 8
care and treatment (7) 7
female (7) 7
melanoma - immunology (7) 7
antibody (6) 6
chemotherapy (6) 6
lymphocytes (6) 6
mice (6) 6
survival (6) 6
tumors (6) 6
male (5) 5
medicine, research & experimental (5) 5
melanoma - therapy (5) 5
mice, inbred c57bl (5) 5
middle aged (5) 5
mutation (5) 5
neoplasms. tumors. oncology. including cancer and carcinogens (5) 5
pembrolizumab (5) 5
research (5) 5
tumor microenvironment (5) 5
antibodies, monoclonal - therapeutic use (4) 4
cancer vaccines - immunology (4) 4
cell biology (4) 4
chemical and pharmacologic phenomena (4) 4
dendritic cells (4) 4
health aspects (4) 4
medical research (4) 4
medicine & public health (4) 4
melanoma - mortality (4) 4
prognosis (4) 4
skin neoplasms - pathology (4) 4
suppressor-cells (4) 4
t cells (4) 4
t-lymphocytes - immunology (4) 4
time factors (4) 4
tumor-infiltrating lymphocytes (4) 4
adult (3) 3
aged (3) 3
aged, 80 and over (3) 3
analysis (3) 3
apoptosis (3) 3
biomarker (3) 3
blockade (3) 3
cd8-positive t-lymphocytes - immunology (3) 3
clinical trials (3) 3
colony-stimulating factor (3) 3
dermatology (3) 3
diagnosis (3) 3
disease progression (3) 3
drug therapy (3) 3
genetic aspects (3) 3
immune checkpoint (3) 3
immunohistochemistry (3) 3
induction (3) 3
lymphocyte-associated antigen-4 (3) 3
lymphocytes, tumor-infiltrating - immunology (3) 3
medical colleges (3) 3
medicine, experimental (3) 3
meeting abstracts (3) 3
metastases (3) 3
neoplasm staging (3) 3
nivolumab (3) 3
phase-i (3) 3
radiotherapy (3) 3
responses (3) 3
retrospective studies (3) 3
skin neoplasms - immunology (3) 3
t-cells (3) 3
treatment outcome (3) 3
tumor (3) 3
vaccine (3) 3
anti-pd1 (2) 2
antibodies (2) 2
antibodies, monoclonal - pharmacology (2) 2
antigens (2) 2
antigens, cd - immunology (2) 2
antineoplastic agents - therapeutic use (2) 2
autoimmune diseases (2) 2
autoimmunity (2) 2
biochemistry & molecular biology (2) 2
biological markers (2) 2
biomarkers (2) 2
breast-cancer (2) 2
cancer research (2) 2
cancer vaccines - therapeutic use (2) 2
cancer--immunotherapy (2) 2
carcinoma, pancreatic ductal - drug therapy (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. e15675 - e15675
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. 9577 - 9577
Journal Article
Current Oncology Reports, ISSN 1523-3790, 12/2018, Volume 20, Issue 12, pp. 1 - 2
A correction was made to a sentence in the original article to provide additional clarification in the “Other Oncolytic Viruses” section. 
Medicine & Public Health | Oncology | Drug therapy | Medical societies | Melanoma
Journal Article
Hematology/Oncology Clinics of North America, ISSN 0889-8588, 2019, Volume 33, Issue 2, pp. 291 - 291
Immunotherapy has drastically improved the prognosis of many patients with cancer, but it can also lead to severe immune-related adverse events. Biomarkers,... 
Immunohistochemistry | Predictive and prognostic biomarkers | Checkpoint inhibition | Immunotherapy | IMMUNE CELLS | PD-1 BLOCKADE | ANTIBODY | STAGE-III | TUMOR-INFILTRATING LYMPHOCYTES | BREAST-CANCER | MELANOMA | ONCOLOGY | HEMATOLOGY | EXPRESSION | T-CELLS | IPILIMUMAB
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2014, Volume 32, Issue 15_suppl, pp. e14010 - e14010
Journal Article
Cancer Immunity, 01/2008, Volume 8, p. 1
Cytotoxic T lymphocyte antigen-4 (CTLA-4) is a negative regulator of T-cell mediated immune responses and is the target of new anti-tumor immunotherapy... 
Human | Case reports | Ipilimumab | Melanoma | Humans | Middle Aged | Antibodies, Monoclonal - therapeutic use | Male | Treatment Outcome | Antineoplastic Agents - therapeutic use | Melanoma - pathology | Disease Progression | Neoplasm Metastasis | Time Factors | Immunotherapy | Female | Melanoma - therapy
Journal Article
Journal for ImmunoTherapy of Cancer, ISSN 2051-1426, 04/2018, Volume 6, Issue 1, pp. 25 - 8
Background: Immunotherapy, in particular checkpoint blockade, has changed the clinical landscape of metastatic melanoma. Nonetheless, the majority of patients... 
Checkpoint inhibitors | Pembrolizumab | Talimogene laherparepvec | Anti-CTLA4 | Ipilimumab | Nivolumab | Melanoma | Brain metastases | Anti-PD1 | T-Vec | EFFICACY | SAFETY | ANTIBODY | IMMUNOLOGY | CANCER | ONCOLOGY | EXPRESSION | Development and progression | Care and treatment | Metastasis | Evidence-based medicine | Immunotherapy | Radiosurgery
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 15_suppl, pp. e21610 - e21610
Journal Article
American Journal of Clinical Dermatology, ISSN 1175-0561, 10/2019
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 15_suppl, pp. 9580 - 9580
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 15_suppl, pp. 12057 - 12057
Journal Article
Nature medicine, ISSN 1078-8956, 04/2019, Volume 25, Issue 6, pp. 1022 - 1022
In the version of this article originally published, the graph in Extended Data Fig. 2c was a duplication of Extended Data Fig. 2b. The correct version of... 
Immunotherapy | PD-1 protein | Glioblastoma
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 15_suppl, pp. 9576 - 9576
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.